- Home
- CTS vs OCUL Comparison
CTS vs OCUL Comparison
Compare CTS & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTS
- OCUL
- Stock Information
- Founded
- CTS 1896
- OCUL 2006
- Country
- CTS United States
- OCUL United States
- Employees
- CTS N/A
- OCUL N/A
- Industry
- CTS Electrical Products
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- CTS Technology
- OCUL Health Care
- Exchange
- CTS Nasdaq
- OCUL Nasdaq
- Market Cap
- CTS 1.6B
- OCUL 1.2B
- IPO Year
- CTS N/A
- OCUL 2014
- Fundamental
- Price
- CTS $48.19
- OCUL $7.85
- Analyst Decision
- CTS Hold
- OCUL Strong Buy
- Analyst Count
- CTS 1
- OCUL 8
- Target Price
- CTS $46.00
- OCUL $16.50
- AVG Volume (30 Days)
- CTS 127.5K
- OCUL 910.1K
- Earning Date
- CTS 02-04-2025
- OCUL 03-10-2025
- Dividend Yield
- CTS 0.34%
- OCUL N/A
- EPS Growth
- CTS N/A
- OCUL N/A
- EPS
- CTS 1.89
- OCUL N/A
- Revenue
- CTS $515,770,999.00
- OCUL $61,442,000.00
- Revenue This Year
- CTS N/A
- OCUL $11.40
- Revenue Next Year
- CTS $5.85
- OCUL $13.58
- P/E Ratio
- CTS $24.94
- OCUL N/A
- Revenue Growth
- CTS N/A
- OCUL 6.45
- 52 Week Low
- CTS $42.20
- OCUL $4.06
- 52 Week High
- CTS $59.68
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- CTS 28.20
- OCUL 40.87
- Support Level
- CTS $44.00
- OCUL $7.45
- Resistance Level
- CTS $52.39
- OCUL $7.89
- Average True Range (ATR)
- CTS 1.34
- OCUL 0.29
- MACD
- CTS -0.41
- OCUL 0.02
- Stochastic Oscillator
- CTS 32.22
- OCUL 51.97
About CTS CTS Corporation
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan and other countries.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.